Navigation Links
Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007

_blank" href= "http://www.amylin.com/">http://www.amylin.com.

This press release contains forward-looking statements about Amylin, which involve risks and uncertainties. Amylin's actual results could differ materially from those discussed herein due to a number of risks and uncertainties, including risks that BYETTA or SYMLIN, and the revenues Amylin generates from these products, may be affected by competition, unexpected new data, technical issues, or manufacturing and supply issues; risks that the results of pre-clinical studies or clinical trials may not be predictive of future results; risks that our clinical trials will not start or be completed when planned; risks that the FDA may not approve Amylin's regulatory submissions; and risks inherent in the drug development and commercialization process. Commercial and government reimbursement and pricing decisions and the pace of market acceptance may also affect the potential for BYETTA or SYMLIN. These and additional risks and uncertainties are described more fully

in Amylin's recently filed Form 10-Q. Amylin disclaims any obligation to update these forward-looking statements.

CONTACT: Alice Bahner Izzo of Amylin Pharmaceuticals, Inc.,+1-858-642-7272, cell, +1-858-232-9072, ; or RachelMartin of Edelman, +1-323-202-1031, cell, +1-323-373-5556,, for Amylin Pharmaceuticals, Inc. alice.izzo@amylin.com rachel.martin@edelman.com

Web site: http://www.amylin.com/http://scientificsessions.diabetes.org/

Ticker Symbol: (NASDAQ-NMS:AMLN)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:2/26/2015)... Ill. , Feb. 26, 2015  Today the ... The psychological and physical side effects of ... that opioid painkillers, such as Vicodin and Oxycontin, are ... "More Americans overdose on prescription painkillers than on heroin ... president and CEO of NSC. "Yet, these medications are ...
(Date:2/26/2015)...  Mail-service and specialty pharmacies will save ... health plans $23.3 billion over the next decade, ... Management Association (PCMA). "Home delivery of ... easiest ways to reduce health costs," said PCMA ... should resist efforts to restrict these cost-saving tools." ...
(Date:2/26/2015)... February 26, 2015 LifeScienceIndustryResearch.com ... First -In- Class Innovations and Cost Optimization Plays ... Cap Pharmaceutical Companies research report to the pharmaceuticals ... to this Global Pharma US & EU Outlook ... measurements, divestment of non-core assets result in healthy ...
Breaking Medicine Technology:National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4
... Roche announced today that a,comparative study conducted to ... blood glucose testing showed ACCU-CHEK blood,glucose monitoring systems ... Results indicated ... blood glucose monitoring systems and the ACCU-CHEK Multiclix, ...
... 1 Genaera Corporation (Nasdaq: GENR ... in study MSI-1436C-102 (Study 102), the multiple ascending dose ... obese type 2 diabetics. MSI-1436 is a novel therapeutic ... which works centrally and peripherally to regulate insulin and ...
Cached Medicine Technology:Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3
(Date:3/1/2015)... Theme and plugin developers from Pixel Film ... for Final Cut Pro X entitled Transccordion. , “Transccordion ... FCPX editors project.” Said Christiana Austin, CEO of Pixel ... to easily drag and drop their accordion transition between ... controls over the parameters of this transition bundle and ...
(Date:2/28/2015)... The MCA Youth Empowerment Conference aims ... platform and gears towards the goal for a better ... group talks in smaller groups will be held after ... Development, Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, Women and ... youths. , Young adults aged between 18-30 ...
(Date:2/28/2015)... 01, 2015 Heart diseases are on ... percent of urban adult population and 5 percent of ... diseases and 20-30 percent of them require specialized investigation ... and coronary vascular diseases (CVD). , A division of ... market research report titled “Indian Coronary Stent Market Forecast ...
(Date:2/28/2015)... Gerald “Solutionman” Haman surveyed over 10,000 ... to innovative thinking. “The #1 block was lack ... tools,” reports Haman, who created the Thinkubator Innovation Studio ... felt that they did not have enough time for ... to stimulate innovation. , Solutionman’s monthly “Accelerating Innovation Training” ...
(Date:2/28/2015)... AB (PRWEB) February 28, 2015 The ... is now a distributor of the machine. The Heart ... of their license, like a franchise model. The goal ... prevent and reverse heart disease. To buy External ... Fit Clinic can help individuals through this process and ...
Breaking Medicine News(10 mins):Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2
... Understanding how ... teleseminar and Q&A session presented by Wiley Long, President of the HSA for America group ... May 21, 2010. ,Reserve a Free Phone Line for the Teleseminar at www.HSAforAmerica.com/teleseminar.htm ,Or ... ...
... Introducing ... a half, the Crown brand has been pioneering paints and new production techniques. Now, Crown ... ... a paint range offers stunning colours with a clear environmental objective. According to Crown, it,s ...
... NEW ORLEANS HIV-infected patients who are falsely diagnosed ... mortality than those who are correctly diagnosed with ... researchers at University of California-San Francisco and Makerere ... falsely diagnosing persons with TB by rapid testing ...
... bullet to help patients with COPD improve their ability to function ... is "do by doing," according to research to be presented at ... presented at the ATS 2010 International Conference in New Orleans. ... tolerance, but it was unknown whether the reduced amount of physical ...
... ... best selling author as featured on Oprah Jennifer Nicole Lee celebrates her one year ... future airings in June, on her birthday, and in July. Her management team has ... 6am, 11am, 3pm, 8pm EST, and June 13th, her birthday, at 2pm, and 11pm ...
... ... Touchstone Saunas will be giving a free iPad and free shipping with ... Saunas utilize the latest technology in their field to provide an unparalleled ... the health benefits that a Touchstone Infrared Sauna can provide while at ...
Cached Medicine News:Health News:Wondering What Will Happen With Your Health Insurance in the Wake of Health Care Reform? 2Health News:earthbalance is Here - Crown Launch New Eco Friendly Paint Range 2Health News:False positives in TB diagnosis lead to real negatives for HIV patients 2Health News:A more active lifestyle crucial for day-to-day function in COPD patients 2Health News:International Fitness Celebrity Jennifer Nicole Lee Celebrates Her One Year Anniversary at HSN 2Health News:Touchstone Saunas Launches Free iPad Promotion 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: